Bernd Wellenzohn
13Patents
3h-index
44Co-inventors
56Inventor score
Filing activity: Nov 5, 2009 → Jun 28, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8642774B2 | Compounds | Chemistry; Metallurgy | 4 | Active |
| US10640486B2 | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors | Human Necessities | 3 | Active |
| US10501440B2 | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors | Human Necessities | 3 | Active |
| US10399961B2 | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8822471B2 | Compounds, pharmaceutical compositions and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8637550B2 | Heteroaryl diamide compounds useful as MMP-13 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8883789B2 | Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors | Chemistry; Metallurgy | 1 | Active |
| US9029360B2 | Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8741892B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US8716277B2 | Substituted imidazole compounds useful as positive allosteric modulators of mGlu5 receptor activity | Chemistry; Metallurgy | 0 | Active |
| US8796467B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US11304929B2 | Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11179371B2 | Triazole benzamide derivatives as GPR142 agonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.